POSSIBILITIES OF CYTOLOGICAL DIAGNOSIS OF LUNG CANCER. REVIEW

Details: Created: 30 September 2023; Hits: 753

Autors:

- VOL 3, No. 3 (2023)
DOI: 10.14489/lcmp.2023.03.pp.035-046
Article type: Review

Continuous numbering: 9
Pages: 35-46
Share:

Heading: Review Articles

Lung cancer (LC) occupies a leading place in the structure of morbidity and mortality among patients with cancer worldwide, which determines LC as an important medical and social problem for health systems.
LC is detected in more than two thirds of patients at a late stage, which determines the low success of therapy and low survival rates, and also actualizes the need to use effective methods (including morphological) for the diagnosis of LC in the early stages.
Due to the development of the minimally invasive vector of morphological diagnostics in recent decades, cytological examination of the material from the bronchopulmonary system is of leading importance, since it is characterized not only by low traumatism in obtaining cellular material, but also by high information content, cost-effectiveness, accessibility and speed of obtaining results. The effectiveness of cytological examination for the diagnosis of precancerous lesions and LC has been proven in numerous studies, and the importance and necessity of its use are reflected in the new edition of the WHO classification of tumors of thoracic localization (2021) and the WHO reporting system for lungs Cytopathology (2022).

Andrey А. Kireev – MD, PhD, Cytopathologist, Clinical Diagnostic Laboratory of the Yudin Clinical Hospital of the Moscow Health Department, Moscow, Russia; Russian Medical Academy of Continuing Professional Education of the Russian Ministry of Health, Moscow, Russia. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Konstantin V. Shchetinin – MD, Oncologist, Deputy Chief Physician for Organizational and Methodological Work of the Orenburg Regional Clinical Oncological Dispensary, Orenburg, Russia. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

1. Martirosova KM, Zhandarova LF, Matveyeva OV. Рossibilities of cytological research method in the diagnosis of lung tumors. MEDICUS. 2020;4(34):32–40. (In Russ).
2. Kosterina NE, Grinberg LM. Algorithm of morphological diagnosis of small cell lung cancer according to bronchial. Ural Medical Journal. 2014;8(122):57–61. (In Russ).
3. Rodionov EO, Tuzikov SA, Miller SV, et al. Methods for early detection of lung cancer (review). Siberian journal of oncology. 2020;19(4):112–22. (In Russ). DOI: 10.21294/1814-4861-2020-19-4-112-122
4. Petty TL. Sputum cytology for the detection of early lung cancer. Curr Opin Pulm Med. 2003;9(4):309–12. DOI: 10.1097/00063198-200307000-00011
5. Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol. 2002;64:681–708. DOI: 10.1146/annurev.physiol.64.081501.155828
6. Layfield LJ, Esebua M. A modified Papanicolaou Society of Cytopathology system for reporting respiratory cytology specimens: Implications for estimates of malignancy risk and diagnostic accuracy. Diagn Cytopathol. 2021;49(11):1167–72. DOI: 10.1002/dc.24840
7. Chraba?ska M, ?roda M, Kiczmer P, et al. Lung Cancer Cytology: Can Any of the Cytological Methods Replace Histopathology? J Cytol. 2020 Jul-Sep;37(3):117–21. DOI: 10.4103/JOC.JOC_168_19
8. de Sousa VML, Carvalho L. Heterogeneity in Lung Cancer. Pathobiology. 2018;85(1–2):96–107. DOI: 10.1159/000487440
9. Arsenyev AI, Nefedova AV, Ganeev AA, et al. Combined early diagnosis of lung cancer by determining the composition of exhaled air by a non-selective method of analysis of volatile organic compounds using metal oxide sensors with cross-sensitivity and cytological examination of sputum. Questions of oncology. 2020;66(4):381–4. (In Russ).
10. Gupta N, Klein M, Chau K, et al. Adequate at rapid on-site evaluation (ROSE), but inadequate on final cytologic diagnosis: Analysis of 606 cases of endobronchial ultrasound-guided trans bronchial needle aspirations (EBUS-TBNA). Diagn Cytopathol. 2019May;47(5):367–73. DOI: 10.1002/dc.24121
11. Takahashi Y, Kuroda H, Oya Y, et al. Challenges for real-time intraoperative diagnosis of high risk histology in lung adenocarcinoma: A necessity for sublobar resection. Thorac Cancer. 2019;10(8):1663–1668. DOI: 10.1111/1759-7714.13133
12. Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33. DOI: 10.3322/caac.21654
13. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. DOI: 10.3322/caac.21660
14. Pathological anatomy according to Robbins: textbook / Vinay Kumar, Abul K Abbas, John S Aster; main ed. ed. in Russian by EA Kogan; translated from English by EA Kogan, AD Sapargalieva. Moscow: GEOTAR-Media, 2022. P. 1136 (In Russ).
15. Laktionov KK, Artamonova EV, Borisova TN, et al. Malignant neoplasm of the bronchi and lung. Clinical recommendations. Modern oncology. 2020;23(3):369–402. (In Russ).
16. Liam CK, Andarini S, Lee P, et al. Lung cancer staging now and in the future, Respirology. 20 (4) (2015) 526–34. DOI: 10.1111/resp.12489
17. Blandin Knight S, Crosbie PA, Balata H, et al. Progress and prospects of early detection in lung cancer. Open Biol. 2017;7(9):170070. DOI: 10.1098/rsob.170070
18. Tahir Mufti Sh, Mokhtar GA. Diagnostic value of bronchial wash, bronchial brushing, fine needle aspiration cytology versus combined bronchial wash and bronchial brushing in the diagnosis of primary lung carcinomas at a tertiary care hospital. Biomed Res 2015;26:777–84.
19. Fuladi AB, Munje RP, Tayade BO. Value of Washings, Brushings, and Biopsy at Fibreoptic Bronchoscopy in the Diagnosis of Lung Cancer. JIACM. 2004;5:137–42.
20. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6(2):244–85. DOI: 10.1097/JTO.0b013e318206a221
21. Kosareva PV, Broyan SA, Samodelkin EI, et al. Transformation of inflammatory changes into malignant ones in the bronchial wall with longterm chronic inflammatory processes. Modern problems of science and education. 2021;5:122. (In Russ).
22. Maghfoor I, Perry MC. Lung cancer. Ann Saudi Med. 2005;25(1):1–12. DOI: 10.5144/0256-4947.2005.1
23. Craig H. Steffee, Lori A. Segletes, Kim R. Geisinger. Changing Cytologic and Histologic Utilization Patterns in the Diagnosis of 515 Primary Lung Malignancies. Cancer Cytopathol, 1997;81:105–15.
24. Fassunke J, Engels M, Meemboor S, et al. Zytopathologie und molekulare Diagnostik von nichtkleinzelligen Lungenkarzinomen (NSCLC) [Cytopathology and molecular diagnostics of non-small cell lung cancer (NSCLC)]. Inn Med (Heidelb). 2022;63(7):694–9. German. DOI: 10.1007/s00108-022-01365-1
25. Travis WD, Brambilla E, Nicholson AG, et al. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015;10(9):1243–60. DOI: 10.1097/JTO.0000000000000630
26. Sareen R, Pandey CL. Lung malignancy: Diagnostic accuracies of bronchoalveolar lavage, bronchial brushing, and fine needle aspiration cytology. Lung India. 2016;33(6):635–41. DOI: 10.4103/0970-2113.192882
27. Inage T, Nakajima T, Yoshino I, et al. Early Lung Cancer Detection. Clin Chest Med. 2018;39(1):45–55. DOI: 10.1016/j.ccm.2017.10.003
28. Grigoruk OG, Pupkova EE, Bazulina LM, et al. The use of cytological material in the diagnosis of lung cancer. Malignant tumors. 2017;7(4):13–20. (In Russ).
29. Mino-Kenudson M. Cytological reporting on lung FNA and small biopsy specimens in the era of personalized medicine. Cancer Cytopathol. 2017;125(3):155–60. DOI: 10.1002/cncy.21793
30. Savostikova MV, Furmanskaya EYu, Eleubaeva ZhB. Modern approach in cytological diagnosis of lung tumors. Oncology and radiology of Kazakhstan. 2017;(45):18–24. (In Russ).
31. Savostikova MV, Fedoseeva ES, Furminskaya EYu. Modern cytomorphological diagnosis of lung tumors. News of clinical cytology of Russia. 2018;22(3–4):3–7. (In Russ).
32. Grigoruk OG. Metastatic lung lesions: cytological method of diagnosis. Siberian Oncological Journal. 2013;8(2):22–3. (In Russ).
33. Noll B, Wang WL, Gong Y, et al. Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations. Cancer Cytopathol. 2018;126(5):342–52. DOI: 10.1002/cncy.21987
34. Filimonova ES, Tarasenko SL, Dykhno YuA, et al. Evaluation of the effectiveness of cytological diagnostics of malignant neoplasms of the. Siberian Medical Review. 2014;3(87):65–9. (In Russ).
35. Li WN, Wang DF, Zhao YB, et al. Comparative Analysis for Diagnostic Yield of Small Cell Lung Cancer by Cytology and Histology During the Same Bronchoscopic Procedure. Clin Lung Cancer. 2017;18(5):e357–e361. DOI: 10.1016/j.cllc.2017.02.009
36. Strimpakos A, Politi E, Kainis E, et al. The clinical significance of cytology versus histology-based diagnosis in small cell lung cancer: a retrospective study. Lung Cancer. 2014;85(2):186–90. DOI: 10.1016/j.lungcan.2014.04.015
37. Denley H, Singh N, Clelland CA. Transthoracic fine needle aspiration cytology of lung for suspected malignancy: an audit of cytological findings with histopathological correlation. Cytopathology. 1997;8(4):223–9. DOI: 10.1046/j.1365-2303.1997.5482054.x
38. Zakowski MF. Cytology Nomenclature and 2015 World Health Organization Classification of Lung Cancer. Cancer Cytopathology. 2016;124(2):81–8. DOI: 10.1002/cncy.21628
39. Nizzoli R, Tiseo M, Gelsomino F, et al. Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer. J Thorac Oncol. 2011;6(3):489–93. DOI: 10.1097/JTO.0b013e31820b86cb
40. Sigel CS, Moreira AL, Travis WD, et al. Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens. J Thorac Oncol. 2011;6(11):1849–56. DOI: 10.1097/JTO.0b013e318227142d
41. Rekhtman N, Brandt SM, Sigel CS, et al. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing. J Thorac Oncol. 2011;6(3):451–8. DOI: 10.1097/JTO.0b013e31820517a3
42. Shapiro NA. Cytological diagnosis of lung diseases: color atlas (Series: “Color Atlases on cytological diagnostics”) / NA Shapiro. Moscow: Reprocenter M, 2005. 28 p. (In Russ).
43. Layfield LJ, Pearson L, Walker BS, et al. Diagnostic Accuracy of Fine-Needle Aspiration Cytology for Discrimination of Squamous Cell Carcinoma from Adenocarcinoma in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Acta Cytol. 2018;62(5–6):318–26. DOI: 10.1159/000493942
44. Layfield LJ, Baloch Z, Elsheikh T, et al. Standardized terminology and nomenclature for respiratory cytology: The Papanicolaou Society of Cytopathology guidelines. Diagn Cytopathol. 2016;44(5):399–409. DOI: 10.1002/dc.23457
45. Auger M, Brimo F, Kanber Y, et al. A practical guide for ancillary studies in pulmonary cytologic specimens. Cancer Cytopathol. 2018;126(Suppl 8):599–614. DOI: 10.1002/cncy.22028
46. Travis WD, Brambilla E, Noguchi M, et al. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med. 2013;137(5):668–84. DOI: 10.5858/arpa.2012-0263-RA
47. Idowu MO, Powers CN. Lung cancer cytology: potential pitfalls and mimics – a review. Int J Clin Exp Pathol. 2010;3(4):367–85.
48. Sareen R, Pandey CL. Lung malignancy: Diagnostic accuracies of bronchoalveolar lavage, bronchial brushing, and fine needle aspiration cytology. Lung India. 2016;33(6):635–41. DOI: 10.4103/0970-2113.192882
49. Rohtagi S, Khan L, Pantola C, et al. Correlationof fine needle aspiration cytology with bronchoalveolar lavage and brush smear cytology in pulmonary lesions. J Evol Med Dent Sci. 2014;3:6957–64.
50. Thivolet-B?jui F. Cytological pitfalls in bronchopulmonary tumors. Diagn Cytopathol. 1997;17(6):412–6. DOI: 10.1002/(sici)1097-0339(199712)17:63.0.co;2-a
51. Nicholson AG, Tsao MS, Beasley MB, et al. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015. J Thorac Oncol. 2022;17(3):362–87. DOI: 10.1016/j.jtho.2021.11.003.
52. Gansler T, Fedewa SA, Lin CC, et al. Variations in cancer centers' use of cytology for the diagnosis of small cell lung carcinoma in the National Cancer Data Base. Cancer Cytopathol. 2016;124(1):44–52. DOI: 10.1002/cncy.21610
53. Giti R, Hosseinzadeh M. Efficacy of Bronchial Washing and Brushing Cytology in the Diagnosis of Non-Neoplastic Lung Diseases. Acta Med Iran. 2017;55(10):636–41.
54. Nodit L, Balassanian R, Sudilovsky D, et al. Improving the quality of cytology diagnosis: root cause analysis for errors in bronchial washing and brushing specimens. Am J Clin Pathol. 2005;124(6):883–92.
55. Crapanzano JP, Saqi A. Pitfalls in pulmonary cytopathology. Diagn Cytopathol. 2011;39(2):144–54. DOI: 10.1002/dc.21396
56. Ahmed A, Ahmed S. Comparison of bronchoalveolar lavage cytology and transbronchial biopsy in the diagnosis of carcinoma of lung. J Ayub Med Coll Abbottabad. 2004;16(4):29–33.
57. Glatz K, Savic S, Glatz D, et al. An online quiz uncovers limitations of morphology in equivocal lung cytology. Cancer. 2006;108(6):480–7. DOI: 10.1002/cncr.22286
58. Saad RS, Silverman JF. Respiratory cytology: differential diagnosis and pitfalls. Diagn Cytopathol. 2010;38(4):297–307. DOI: 10.1002/dc.21205
59. Thivolet-B?jui F. Cytological pitfalls in bronchopulmonary tumors. Diagn Cytopathol. 1997;17(6):412–6. DOI: 10.1002/(sici)1097-0339(199712)17:63.0.co;2-a
60. Volchenko NN, Borisova OV, Melnikova VYu, et al. Urgent morphological diagnostics in oncology. Oncology. Journal named after P.A. Herzen. 2020;9(1):5–13. (In Russ).
61. Gupta N, Klein M, Chau K, et al. Adequate at rapid on-site evaluation (ROSE), but inadequate on final cytologic diagnosis: Analysis of 606 cases of endobronchial ultrasound-guided trans bronchial needle aspirations (EBUS-TBNA). Diagn Cytopathol. 2019;47(5):367–73. DOI: 10.1002/dc.24121
62. Yuan M, Wang Y, Yin W, et al. Efficacy of rapid on-site cytological evaluation (ROSE) by a pulmonologist in determining specimen adequacy and diagnostic accuracy in interventional diagnosis of lung lesions. J Int Med Res. 2021;49(2):300060520982687. DOI: 10.1177/0300060520982687
63. Xu C, Wang Y, Wang W, et al. Improved diagnostic yield of transbronchial lung biopsy in peripheral pulmonary lesions using a combination of endobronchial ultrasound and rapid on-site evaluation. J Int Med Res. 2021;49(3):300060521999535. DOI: 10.1177/0300060521999535
64. Jain D, Allen TC, Aisner DL, et al. Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med. 2018Feb;142(2):253–62. DOI: 10.5858/arpa.2017-0114-SA
65. Lin O, Rudomina D, Feratovic R, et al. Rapid on-site evaluation using telecytology: A major cancer center experience. Diagn Cytopathol. 2019;47(1):15–9. DOI: 10.1002/dc.23925
66. Sugiyama T, Tajiri T, Fujita H, et al. Diagnostic utility and pitfalls of intraoperative pulmonary imprint cytology based on final pathological diagnoses. Cytopathology. 2019;30(1):74–81. DOI: 10.1111/cyt.12649
67. Wang H, Wei N, Tang Y, et al. The Utility of Rapid On-Site Evaluation during Bronchoscopic Biopsy: A 2-Year Respiratory Endoscopy Central Experience. Biomed Res Int. 2019;2019:5049248. DOI: 10.1155/2019/5049248
68. Huang Z, Zhuang D, Feng A, et al. Real-time and accuracy of rapid on-site cytological evaluation of lung cancer. Transl Cancer Res. 2021;10(1):479–86. DOI: 10.21037/tcr-20-3294
69. Cardoso AV, Neves I, Magalh?es A, et al. The value of rapid on-site evaluation during EBUS-TBNA. Rev Port Pneumol. 2015;21(5):253–8. DOI: 10.1016/j.rppnen.2015.02.003
70. Gupta N, Klein M, Chau K, et al. Adequate at rapid on-site evaluation (ROSE), but inadequate on final cytologic diagnosis: Analysis of 606 cases of endobronchial ultrasound-guided trans bronchial needle aspirations (EBUS-TBNA). Diagn Cytopathol. 2019;47(5):367–73. DOI: 10.1002/dc. 24121
71. Walia S, Aron M, Hu E, et al. Utility of rapid on-site evaluation for needle core biopsies and fine-needle aspiration cytology done for diagnosis of mass lesions of the liver. J Am Soc Cytopathol. 2019;8(2):69–77. DOI: 10.1016/j.jasc.2018.08.001
72. Shield PW, Cosier J, Ellerby G, et al. Rapid on-site evaluation of fine needle aspiration specimens by cytology scientists: a review of 3032 specimens. Cytopathology. 2014;25(5):322–9. DOI: 10.1111/cyt.12157
73. Volchenko NN, Borisova OV, Melnikova VYu, et al. Intraoperative urgent cytological diagnostics in oncology. News of clinical cytology of Russia. 2019;23(2):5–11. (In Russ).
74. Akyildiz EU. Intraoperative pathology consultation for pulmonary lesions: errors and deferrals. Int J Clin Exp Pathol. 2015;8(7):7961–6.
75. Sienko A, Allen TC, Zander DS, et al. Frozen section of lung specimens. Arch Pathol Lab Med. 2005;129(12):1602–9. DOI: 10.5858/2005-129-1602-FSOLS
76. Kruglova IA, Paranina TV, Samsonova ES. The role of urgent intraoperative cytological examination in the differential diagnosis of irreversible lung formations/ Fundamental and applied scientific research: topical issues, achievements and innovations: collection of articles of the VI International Scientific and Practical Conference. Penza: Science and Education, 2017:361–3. (In Russ)

The article can be purchased
electronic!

PDF format

Free

https://lcmpub.com/archive/lcmp_2023_03/lcmp_2023_03_pp_035_046.pdf

DOI: 10.14489/lcmp.2023.03.pp.035-046
Article type: Review
Make a request

Keywords

lung cancer, сytological diagnosis of lung cancer, cytological examination.

Use the reference below to cite the publication

Kireev AA, Shchetinin KV. Possibilities of cytological diagnosis of lung cancer. Review. Laboratory and Clinical Medicine. Pharmacy. 2023;3(3):35-46. (In Russ). DOI: 10.14489/lcmp.2023.03.pp.035-046